What Ben Sasse's Diagnosis Can Help Us Understand About Pancreatic Cancer

In the news

In December 2025, former U.S. Senator Ben Sasse, who had also served as a university president, shared publicly that he had been diagnosed with stage IV (advanced) pancreatic cancer at age 53. It was widely reported that he shared the news openly while stepping back from some of his responsibilities to focus on treatment and family.

We share only what was publicly reported, and we do not speculate about any private details of his care.

The reality

According to the National Cancer Institute, pancreatic cancer can develop from two kinds of cells in the pancreas. NCI explains that cancers arising from exocrine cells are the more common type and are usually found at an advanced stage. A second, less common group — pancreatic neuroendocrine tumors, also called islet cell tumors — tends to have a better prognosis. "Stage IV" means the cancer has spread beyond the pancreas to other parts of the body; wherever it travels, it is still pancreatic cancer, named for where it began. One reason pancreatic cancer is often found late is that the pancreas sits deep in the abdomen and early disease may not cause obvious symptoms.

What the story gets right — and what to remember

Mr. Sasse's openness reflects how pancreatic cancer is frequently diagnosed at a later stage. But a diagnosis, even an advanced one, does not tell the whole story of any one person — treatments, responses, and experiences vary widely. His story is a way to learn and to approach a difficult subject with honesty and compassion, not a prediction about anyone else, and not medical advice.

Awareness, screening & prevention

Here it is important to be straightforward. NCI states plainly that it does not have evidence-based information about screening for pancreatic cancer, and that it does not have evidence-based information about preventing it. In other words, there is no recommended routine screening test for pancreatic cancer for people at average risk. Rather than a screening schedule, NCI's guidance points people toward general awareness and follow-up on new or persistent symptoms with a healthcare professional, who can decide whether further evaluation makes sense. We won't invent prevention or screening advice that NCI does not support.

Turning a story into something useful

When someone shares a serious diagnosis so openly, the kindest and most useful response is often to listen, to learn accurately, and to support one another. Understanding what pancreatic cancer is — and being honest about what medicine can and cannot yet do to screen for it — helps replace fear with clear information. Supporting free, trustworthy cancer education, and the research that drives progress, helps that information and hope reach more people.

Questions to ask a healthcare team

• What does a stage IV diagnosis mean for the options available?
• What are the possible benefits and risks of the treatments being considered?
• What support is available for symptoms, nutrition, and emotional wellbeing?
• Are there clinical trials that might be appropriate to ask about?